Ben Hargreaves speaks to Liberate Bio, a company that is hoping to address the delivery issues that could prevent mRNA, as well as siRNA and ASO therapeutics, from reaching their full potential.

Welcome to the Money blog, Sky News' personal finance and consumer hub. Today: our weekly Cheap Eats feature, in which a top chef tells us his most controversial opinion. And good mortgage news ...